Navigating the 2024 PAD Guidelines
1:01:00
Discussion of 2023 AFib Guidelines
1:00:57
Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
1:13:49
Managing HTAD: Key Insights from the 2024 ESC Guidelines
1:13:22
Koroner Arter Hastalıkları Tedavi (ESC 2024 Kılavuzu)
59:31
Anticoagulants in Older Adults
42:25
Peripheral Arterial Disease for the Internist
27:28
SHKH: "NHỮNG ĐIỂM CHÍNH TẠI HỘI NGHỊ ESC 2024"
1:03:18